|
|
|
This is the preliminary program for the 2008 Joint Statistical
Meetings in Denver, Colorado.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2008 Program page |
= Applied Session,
= Theme Session,
= Presenter|
|
||
494
|
Thu, 8/7/08, 10:30 AM - 12:20 PM | CC-207 |
| Imaging Biomarkers in Oncology - Invited - Papers | ||
|
Biopharmaceutical Section, WNAR, Biometrics Section |
||
| Organizer(s): William L. Mietlowski, Novartis Pharmaceuticals | ||
| Chair(s): William L. Mietlowski, Novartis Pharmaceuticals | ||
| 10:35 AM |
Practical Considerations in Exploratory Imaging —  Haren Rupani, Novartis Pharmaceuticals
|
|
| 11:00 AM |
Imaging Modalities Can Predict Therapy Outcomes: Can They Be Used To Define Endpoints in Clinical Trials? — Constantine Gatsonis, Brown University
|
|
| 11:25 AM |
Evaluation of Novel Imaging Agents in the Context of Treatment Effects — Lori E. Dodd, National Cancer Institute
|
|
| 11:50 AM | Disc: Sue-Jane Wang, U.S. Food and Drug Administration | |
| 12:10 PM | Floor Discussion | |
|
JSM 2008
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |